Abstract:
Background: Previous reports of altered grey and white matter structure in Major Depressive Disorder (MDD) have been inconsistent. Recent meta-analyses have, however, reported reduced hippocampal grey matter volume in MDD and reduced white matter integrity in several brain regions.
The use of different diagnostic criteria, different scanners and imaging sequences may, however, obscure further anatomical differences.
Methods: In this study, we tested for differences in subcortical grey matter volume and white matter integrity between depressed individuals and controls in a large sample of subjects from the first data release of the UK Biobank imaging study of 4446 individuals, which used consistent diagnostic criteria at a single assessment centre, with a single MRI scanner and protocol.
Results: Whilst we found no significant differences in subcortical volumes, we report significant reductions in depressed individuals versus controls in global white matter integrity, as measured by fractional anisotropy (FA) (β = -0.187, p = 0.017). We also report reductions in FA in association/commissural fibres (β = -0.184, p = 0.019) and thalamic radiations (β = -0.175, p = 0.027).
Examining tracts individually, we report tract-specific FA reductions in the left superior longitudinal fasciculus (β = -0.218, p corrected = 0.012) and superior thalamic radiation (β = -0.258, p corrected = 0.010) in subjects with depression. 
Introduction
Major Depression Disorder (MDD) is a common psychiatric illness, affecting between 5 and 30% of the population (1) and accounts for around 10% of all days lived with disability (2) . There is therefore an urgent need to identify the mechanisms underlying MDD (3; 4) and human in vivo MRI has been widely applied in this search.
Many brain imaging studies have measured grey matter volume differences between healthy individuals and, predominantly clinically ascertained, individuals with MDD. On the basis that prefrontal cortex and limbic areas are fundamental to emotion processing and mood regulation (5-7), these areas have been consistently implicated in the disorder (8) (9) (10) (11) .
As the use of automated methods such as voxel-based morphometry (12; 13) and Freesurfer (14; 15) have increased, this has expanded the search across the whole brain. In general, structural abnormalities have been reported across diverse brain networks in MDD. Regions including the thalamus (16), The lack of a single lesion or anatomically circumscribed abnormality in MDD has led many to suggest that the disorder might be due to abnormalities of brain networks affecting connections between several regions. In support of this, findings from individual studies of white matter structure in MDD have shown patterns of alteration using diffusion tensor imaging (DTI). Proxy measures of white matter integrity, including fractional anisotropy (FA) and mean diffusivity (MD), have generally been used to infer connectivity differences between groups. Decreased FA indicates lower directionality of water molecule diffusion along fibre pathways and is therefore a proxy of decreased tract integrity, whilst increased MD indicates less constrained water molecule diffusion and therefore also lower integrity.
White matter integrity of frontal-limbic tracts have been suggested to underlie clinical features in MDD due to a lack of frontal cortical control over brain regions that involve in emotion processing (23-27 samples where robust conclusions can be made in the absence of differing study methodologies.
In the current study, we examined the volumetric structural imaging data of subcortical brain structures and tract-specific white matter integrity measures from the UK Biobank imaging study (33) . UK Biobank is a study of 500,000 subjects recruited from across the United Kingdom. The dataset used in the current study is the first release of imaging data on 4446 participants who completed the brain imaging assessment. The scanning protocol was devised by UK Biobank, with consistent, compatible setting of scanner parameters and participant-friendly experimental procedures. This data therefore allowed us to explore structural changes associated with depression in a single large population-based sample using data from an individual study source with unified depression classification, and with scanning sequences and image processing procedures applied consistently across all subjects, all of whom were imaged on a single MRI scanner. Individuals from the initial pilot phase of imaging using different acquisition parameters were excluded from the current study as were, those that did not complete pre-processing quality checks (conducted by UK Biobank). In addition, scans from individuals that were identified by our internal quality check as having a structural measure that lay more than three standard deviations from the sample mean were excluded. Any participants that had a diagnosis of Parkinson's Disease, bipolar disorder, multiple personality disorder, schizophrenia, autism or intellectual disability were also excluded from the current analysis (ICD-10/9 or self-report 47.82% for those with DTI measures). Details of data exclusions were in the supplementary materials (Method, Participants).
MDD definitions
The definition of MDD used in the current study was generated based on the putative MDD category summarized previously by Smith et al., as presented in supplementary materials (Table S1 ) (34). They generated the criteria of single episode major depression, recurrent major depression (moderate), recurrent major depression (severe) and those who were absent of depression. This category was benchmarked by testing its prevalence in the sample, and by testing for association with a number of traits, such as neuroticism (35) that have previously been associated with MDD (36).
However, since the category is based on hospital admission data and depressive symptoms, which were both self-reported, rather than more formal ICD/SCID criteria, we considered the cases more strictly as 'probable' MDD and results should be viewed accordingly.
We generated two definitions of probable MDD. One was the principal MDD definition that compared MDD patients with healthy controls, while the other was the recurrent MDD definition which compared recurrent MDD patients with non-recurrent and non-MDD individuals.
The principal MDD definition included those who were categorised in single episode major depression, recurrent major depression (moderate) and Table S2 ).
MRI acquisition and analyses
We used the imaging-derived phenotypes (IDPs) generated by UK Biobank (Table S4 ). Tract-averaged FA for each tract was calculated for further analysis.
Scans with severe and obvious normalization problems were excluded by UK Biobank. We also excluded outliers from analysis, as detailed above.
Observations that were more than 3 standard deviation from the sample mean were classed as outliers and were excluded from the analysis of subcortical volumes. For DTI measures, participants with at least one tract-averaged FA more than 3 standard deviation from the mean for the sample were excluded for that measure. Descriptions of the sample were reported in supplementary materials (Table S2) . Table S3 ).
White matter integrity:
In order to test for an association between probable MDD and FA, as above we used a general linear model with age, age 2 and sex as covariates and the definition of MDD as a fixed factor. First we MDD definition and its interaction with hemisphere were tested. Where the interaction was significant, tests were applied individually for left and right sides separately. FDR correction was individually applied over the three subsets of white matter tracts as well as individual tracts (45) . 
Results

The effect of MDD definitions on subcortical volumes
We found no significant group effect for ICV based on the principal definition of MDD (β = 0.026, p = 0.677). There were also no significant differences between groups based on the principal definition of MDD for any of the subcortical brain regions, including the hippocampus (βs = -0.060~0.071, p corrected > 0.566); see Fig. 1 , Table S3 . No region demonstrated significant interaction of hemisphere, therefore no region was examined separately on different hemispheres.
The same models were also applied to compare groups according to the recurrent definition, see above. No subcortical regions reached significance in this definition of recurrent cases versus controls, with the greatest effect size observed for the putamen (β = 0.071, p uncorrected = 0.197).
The effect of probable MDD on measures of white matter integrity
Firstly we tested the effect of probable MDD on general white matter FA (gFA). For both the principal and recurrent definitions, gFA was lower in cases versus controls (β = -0.186, p = 0.016; β = -0.182, p = 0.027 respectively).
We then examined tracts categorised into association fibres, thalamic We then proceeded to compare FA values in the individual tracts between cases and controls. Initially, we tested the tracts controlling for hemisphere effects. Then we tested the interaction of hemisphere and probable MDD definitions on bilateral tracts to identify any lateralised effects. There was a significant interaction of hemisphere in superior longitudinal fasciculus for recurrent definition of probable MDD (β = 0.154, p corrected = 0.013). The left and right superior longitudinal fasciculi were therefore tested separately.
We found reduced FA in the superior thalamic radiations for the principal definition of MDD versus controls (β = -0.258, p corrected = 0.01) (Fig. 2 , Table   S3 ). There was, however, no significant effect of the recurrent MDD definition on superior thalamic radiation FA (β= -0.234, p corrected = 0.081) although the effect size was similar in magnitude. We also found a significant association of MDD with the left superior longitudinal fasciculus for both principal (β = 
Discussion
In the current study we sought to determine whether MDD was associated with differences in subcortical grey matter volume or white matter integrity in a large imaging dataset from a single scanner of more than 4000
individuals. The sample sizes of MDD cases and controls included in the analyses of white matter integrity is by far the largest to our knowledge. Whilst we did not find any statistically significant subcortical volumetric differences between unaffected participants and individuals with probable MDD (using any of the definitions with increasing severity), we did find substantial evidence of reduced white matter integrity in MDD. This was seen globally, in two of the three categories of tracts (association and commissural fibres, and thalamic radiation tracts), and in individual tracts (bilateral superior thalamic radiations and left superior longitudinal fasciculus). Similar patterns of findings were seen for both principal and recurrent definition of depression with generally greater effect sizes in recurrent cases, with the exception of the localised differences in the superior thalamic radiation.
Our study notably did not find evidence for bilateral hippocampal volume reduction as previously reported in the large collaborative meta-analysis of MDD (32). We also did not find evidence of reductions in hippocampal volume when looking at recurrent MDD as published in the same review. The lack of subcortical volumetric differences associated with probable MDD diagnoses in the current study therefore does not support the widely held belief that there are subcortical volumetric changes associated with the disorder. There are several potential explanations for this. Firstly, the UK Biobank dataset included only community-dwelling, ambulant individuals who could independently complete the health and cognitive assessments, and attend the follow-up imaging assessments. This approach arguably selected MDD groups that were more well/better functioning but equally more representative of the general population than purely clinically ascertained samples. We also used a composite 'probable' MDD diagnosis that was based on self-report symptoms and hospital admission statistics. In contrast, many other studies previously used a structured clinical interview schedule, such as the Structured Clinical Interview for DSM-IV (SCID), to define MDD according to standard criteria. Whilst the probable MDD definitions used in the current paper were not based on an interview, they showed many of the same epidemiological and risk-factor associations as clinically defined cases (34; 46).
Although we do not report subcortical volume differences, we did find substantive evidence for robust deficits in both global and local white matter integrity. We found that MDD patients had global loss of FA which was also found to be reduced in association and commissural fibres as well as in thalamic radiations, but not in projection fibres. FA in these structures was also more severely reduced in the recurrent MDD patients. The above results also consistent with findings from resting-state fMRI studies, which reported abnormalities in MDD populations in regional networks rather than just individual regions or structures (11; 51; 52) . The networks that derive from prefrontal cortex and thalamus has been found largely contribute to emotional and social cognition processes (23). The reduced integrity in these groups of tracts may therefore reflect the repeatedly found impairment of emotion associated with various cognitive dysfunctions, like working memory (63) and attention (61) . Severity of depressive symptoms was also found correlate with FA loss in superior longitudinal fasciculus (64) . There is increasingly convincing evidence therefore that reduced integrity in superior longitudinal fasciculus might be an important feature of the neurobiology of MDD and may underlie impaired emotional process and cognitive abilities in MDD population (30).
Two potential limitations of the current study should be considered, these include the absence of a structured diagnostic interview schedule and the lack of hospital-based sampling. The large sample size may, however, overcome some of these difficulties and community based population sampling may yield more generalizable findings than those based on clinically ascertained samples alone (12; 65; 66) . The current investigation, by avoiding the combination of clinically and methodologically diverse samples, may also have ameliorated several important confounds. The second limitation is that for the volumetric analysis we only focused on the subcortical volumes in the current study. We can therefore not exclude the possibility of cortical differences in MDD, including regional volume differences, as well as measures of cortical thickness and gyrification for example.
Our study presents a comprehensive comparison of brain structural changes related to MDD using the largest single sample available to date 
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